Clincosm LogoSign in Get a demo

Peripheral Artery Disease

Showing 26 - 50 of 295
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The EasyFlype/EasyHiFlype Post Market Clinical Follow-up Study.

Not yet recruiting
  • Peripheral Artery Disease
  • Peripheral Arterial Occlusive Disease
  • Easy Flype/EasyHiFlype
  • Firenze, Italy
  • +1 more
Nov 8, 2022

Peripheral Artery Disease Trial in Gainesville, Chicago, New Orleans (Metformin, Placebo)

Recruiting
  • Peripheral Artery Disease
  • Gainesville, Florida
  • +4 more
Nov 14, 2022

BD Sirolimus Drug Coated Catheter for Treatment of

Recruiting
  • Peripheral Arterial Disease
  • +2 more
  • BD™ Sirolimus Drug Coated Balloon Catheter angioplasty
  • Grafton, Auckland, New Zealand
    Auckland City Hospital
Nov 10, 2022

Peripheral Artery Disease Trial in Chicago (intermittent pneumatic compression, exercise, Sham device)

Recruiting
  • Peripheral Artery Disease
  • intermittent pneumatic compression
  • +3 more
  • Chicago, Illinois
  • +1 more
Nov 13, 2022

Claudication, Intermittent, Peripheral Artery Disease, Peripheral Vascular Diseases Trial in Worcester (Tetrahydrobiopterin 10

Recruiting
  • Claudication, Intermittent
  • +2 more
  • Tetrahydrobiopterin 10 mg/kg
  • +3 more
  • Worcester, Massachusetts
    UMASS Memorial Healthcare - University Campus
Nov 2, 2022

Peripheral Artery Disease Trial in Ferrara (Structured home-based exercise, Walking advice)

Active, not recruiting
  • Peripheral Artery Disease
  • Structured home-based exercise
  • Walking advice
  • Ferrara, Italy
    University Hospital of Ferrara
Nov 2, 2022

Peripheral Artery Disease Trial in São Paulo (Exercise)

Completed
  • Peripheral Artery Disease
  • Exercise
  • São Paulo, Brazil
    Universidade Nove de Julho
Oct 18, 2022

Vascular Diseases, Peripheral Artery Disease, Peripheral Vascular Diseases Trial in Plano (Vascular Rehabilitation)

Terminated
  • Vascular Diseases
  • +2 more
  • Vascular Rehabilitation
  • Plano, Texas
    Baylor Scott & White Heart Hospital- Plano
Oct 12, 2022

Peripheral Artery Disease Trial in Philadelphia (Opt-out)

Recruiting
  • Peripheral Artery Disease
  • Opt-out
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 12, 2022

PAtient Similarity for Decision-Making in Prevention of

Not yet recruiting
  • Heart Failure
  • +7 more
  • Clinical Decision Aid
  • Standard Care
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Oct 5, 2022

Peripheral Artery Disease Trial in Philadelphia (Gamification and Social Incentives)

Recruiting
  • Peripheral Artery Disease
  • Gamification and Social Incentives
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 30, 2022

Peripheral Artery Disease Trial in China (the spot stent(ZENFLEX ® Pinto) system, the bare stent( Everflex) system)

Not yet recruiting
  • Peripheral Artery Disease
  • the spot stent(ZENFLEX ® Pinto) system
  • the bare stent( Everflex) system
  • Beijing, China
  • +11 more
Sep 27, 2022

Peripheral Artery Disease Trial in Chicago (PAD education video)

Recruiting
  • Peripheral Artery Disease
  • PAD education video
  • Chicago, Illinois
    Northwestern University
Sep 28, 2022

Peripheral Artery Disease Trial in Cleveland (iOCT)

Completed
Has Results
  • Peripheral Artery Disease
  • Contrast Injection
  • +3 more
  • Cleveland, Ohio
    University Hospitals Case Medical Center
Aug 25, 2022

Peripheral Artery Disease Trial in New York (Percutaneous Revascularization of the Femoropopliteal Arteries using a DAS,

Active, not recruiting
Has Results
  • Peripheral Artery Disease
  • Percutaneous Revascularization of the Femoropopliteal Arteries using a DAS
  • Percutaneous Revascularization of the Femoropopliteal Arteries using a OAS device
  • New York, New York
    New York University School of Medicine
Jul 26, 2022

Peripheral Artery Disease Trial in Beijing (Sirolimus-eluting balloon catheter, Paclitaxel-eluting balloon catheter)

Recruiting
  • Peripheral Artery Disease
  • Sirolimus-eluting balloon catheter
  • Paclitaxel-eluting balloon catheter
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Aug 17, 2022

Peripheral Artery Disease Trial in Beijing (DEB catheter)

Recruiting
  • Peripheral Artery Disease
  • DEB catheter
  • Beijing, Beijing, China
    Chui Yang Liu Hospital affiliated to Tsinghua University
Aug 17, 2022

BIOLUX P-III All-Comers Passeo-18 Lux Registry

Completed
  • Atherosclerosis
  • Peripheral Artery Disease
  • Passeo-18 Lux
  • Cairns, Australia
  • +44 more
Aug 12, 2022

Tobacco Cessation, Peripheral Artery Disease Trial in Oklahoma City (Tobacco Treatment Research Program Standard Care)

Not yet recruiting
  • Tobacco Cessation
  • Peripheral Artery Disease
  • Tobacco Treatment Research Program Standard Care
  • Oklahoma City, Oklahoma
    TSET Health Promotion Research Center
Aug 2, 2022

Peripheral Artery Disease Trial in Germany, United States (Intravascular Lithotripsy)

Enrolling by invitation
  • Peripheral Artery Disease
  • Intravascular Lithotripsy
  • Fresno, California
  • +41 more
Jul 26, 2022

Peripheral Artery Disease, Atherosclerosis, Arterial Disease of Legs Trial in Korea, Republic of, Singapore, Taiwan (MagicTouch

Recruiting
  • Peripheral Artery Disease
  • +2 more
  • MagicTouch PTA Sirolimus drug coated balloon
  • POBA balloon
  • Seoul, Korea, Republic of
  • +12 more
Jul 21, 2022

BIOTRONIK Dynetic-35 Stent for Treatment of Peripheral Iliac

Recruiting
  • Peripheral Artery Disease
  • Ballon expandable stent and PTA
  • Graz, Austria
  • +12 more
Jul 19, 2022

Peripheral Artery Disease Trial (Leg heat therapy, Sham Control)

Not yet recruiting
  • Peripheral Artery Disease
  • Leg heat therapy
  • Sham Control
  • (no location specified)
Jul 15, 2022

Peripheral Artery Disease Trial in Seoul (Cilostazol, Probucol)

Completed
  • Peripheral Artery Disease
  • Cilostazol, Probucol
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 14, 2022

Peripheral Artery Disease, Peripheral Vascular Disease Trial in Palo Alto (High PAD risk Alert)

Not yet recruiting
  • Peripheral Artery Disease
  • Peripheral Vascular Disease
  • High PAD risk Alert
  • Palo Alto, California
    Stanford University
Jul 11, 2022